Combination of markers at the estrogen- and vitamin...

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/68 (2006.01)

Patent

CA 2343049

The present invention relates to a method for determining an individual's predisposition to osteoporosis, development of osteoporosis and/or responsiveness to therapy for osteoporosis. The method comprises the step of determining the estrogen receptor genotype and the vitamin D receptor genotype of the individual, thereby determining an individual's predisposition to osteoporosis, development of osteoporosis and/or responsiveness to therapy for osteoporosis.

L'invention concerne un procédé pour déterminer la prédisposition d'un individu à l'ostéoporose, le développement de l'ostéoporose et/ou la réactivité au traitement de l'ostéoporose. Ledit procédé consiste à déterminer le génotype du récepteur des oestrogènes et du récepteur de la vitamine D de l'individu, et à déterminer ainsi la prédisposition de celui-ci à l'ostéoporose, le développement de l'ostéoporose et/ou la réactivité au traitement de l'ostéoporose.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination of markers at the estrogen- and vitamin... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination of markers at the estrogen- and vitamin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of markers at the estrogen- and vitamin... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1431851

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.